StockData

Conmed vs TransMedics

CNMD and TMDX side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CNMD and TMDX compare

TransMedics is the larger company, worth 2.3 times as much as Conmed ($3.3B against $1.4B).

On earnings, Conmed is cheaper: it trades at 20.0× trailing earnings, against 24.4× for TransMedics.

TransMedics grew revenue faster over the last twelve months (25.8% versus 1.6% for Conmed).

TransMedics keeps more of each dollar of sales as profit, with a net margin of 22.7% compared with 5.4% at Conmed.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCNMDTMDX
Size and price
Market cap$1.4B$3.3B
Share price$48.39$93.91
Change, 1 year15.1%−18.3%
Change, 5 years−64.2%329%
Beta (5Y)0.380.77
Employees3,900898
StockData Score
Total score1414
Valuation score6 (better)5
Growth score22
Performance score4 (better)3
Health score24 (better)
Dividend score00
Valuation
P/E20.0× (better)24.4×
P/S1.1× (better)4.9×
P/B1.4× (better)6.3×
EV/EBITDA16.3× (better)23.8×
P/FCF10.9× (better)41.2×
FCF yield9.2% (better)2.4%
Fair value$67.87$131.38
Margin of safety28.7% (better)28.5%
Growth
Revenue growth (TTM)1.6%25.8% (better)
Revenue growth, 5Y average9.8%88.2% (better)
Net income growth (TTM)14.6%112% (better)
EPS growth (TTM)18.0%99.5% (better)
EPS growth, 5Y average36.4%–
Profitability
Gross margin57.6%58.7% (better)
Operating margin9.9%12.2% (better)
Net margin5.4%22.7% (better)
FCF margin9.7%11.8% (better)
Return on equity7.1%36.3% (better)
Return on invested capital5.2%–
Financial health
Debt / equity0.770.04 (better)
Net debt / EBITDA5.66 (better)−3.84
Interest coverage4.1× (better)3.8×
Current ratio1.496.62 (better)
Altman Z-score1.992.91 (better)
Piotroski F-score66
Dividends and buybacks
Dividend yield0.00%0.00%
Payout ratio8.4%–
Years of dividend growth00
Dividend growth, 5Y average−5.6%–
Shareholder yield0.00%0.00%
Ownership
Held by institutions114%100%
Held by insiders0.47%3.9%
Insider net buying, 12 months$0 (better)−$4.2M
Short interest, % of float6.3%26.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.